Composition

A protein-based composition with black cumin, parfia, and eleuthero enhances muscle mass and strength, addressing the lack of effective supplements by incorporating specific plant materials for improved muscle maintenance and taste.

JP2024160940APending Publication Date: 2024-11-15TOYO SHINYAKU KK
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2024060778
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-02
Filing Date
2024-04-04
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing nutritional supplements containing protein lack sufficient research on combinations with specific plant materials that effectively maintain and/or increase muscle mass and strength, and improve palatability.

Method used

A composition comprising protein and at least one plant material selected from black cumin, parfia, and eleuthero, with specific ranges of active ingredients such as thymoquinone, 20-hydroxyecdysone, and eleutheroside, to enhance muscle mass, strength, and palatability.

Benefits of technology

The composition effectively maintains and increases muscle mass and strength while improving taste, with mitochondrial activation and amino acid absorption promotion effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024160940000001
    Figure 2024160940000001
  • Figure 2024160940000002
    Figure 2024160940000002
  • Figure 2024160940000003
    Figure 2024160940000003
Patent Text Reader

Abstract

To provide a composition which has excellent effects on maintenance and / or increase of muscle mass or maintenance and / or improvement of muscular strength.SOLUTION: A composition contains protein and a specific plant material.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition containing a protein and at least one specific plant material selected from black cumin, Pfaffia, and Eleuthero. [Background technology]

[0002] Traditionally, nutritional supplements made by powdering protein and taking it with water or other liquids were only consumed by a select few athletes and were not very familiar to the general public. However, in recent years, due to growing interest in health and other factors, opportunities for the general public to consume such supplements have been increasing.

[0003] In recent years, dietary supplements mainly composed of protein are often taken for the purpose of weight gain, and a dietary supplement containing low molecular weight protein, fructose, and black pepper extract is known as a dietary supplement that can effectively increase weight (Patent Document 1). However, there has been insufficient research on combinations of proteins and specific ingredients that are effective in maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] JP 2019-149984 A Summary of the Invention [Problem to be solved by the invention]

[0005] An object of the present invention is to provide a composition containing a protein and at least one plant material selected from black cumin, Pfaffia, and Eleuthero. [Means for solving the problem]

[0006] In order to solve the above problems, the applicant has conducted extensive research into various substances and has surprisingly found that a composition containing a protein and at least one plant material selected from black cumin, Pfaffia, and Eleuthero can be obtained that is excellent in the effects of maintaining and / or increasing muscle mass, maintaining and / or improving muscle strength, and improving palatability. The present invention has been completed based on such findings.

[0007] The outline of the present invention is as follows. <1> A composition comprising a protein and at least one plant material selected from black cumin, Pfaffia, and Eleuthero. <2> A composition comprising as active ingredients a protein and at least one plant material selected from black cumin, Pfaffia and Eleuthero. <3> A composition comprising a protein as an active ingredient and further comprising at least one plant material selected from black cumin, Pfaffia and Eleuthero. <4> The protein content in the composition is 20% by mass or more. <1> ~ <3> 13. The composition according to any one of claims 1 to 12. <5> For maintaining and / or increasing muscle mass; <1> ~ <3> 2. The composition according to claim 1 . <6> For maintaining and / or improving muscle strength; <1> ~ <3> 13. The composition according to any one of claims 1 to 12. <7> A composition comprising a protein and black cumin, the composition containing 0.0001 to 20% by mass of thymoquinone. <8> A composition comprising a protein and Pfaffia, the composition containing 0.00001 to 10% by mass of 20-hydroxyecdysone. <9> 1. A composition comprising a protein and Acanthopanax senticosus Hsinopecius, the composition containing 0.00001 to 10% by mass of eleutheroside. Effect of the Invention

[0008] The composition of the present invention is excellent in the effects of maintaining and / or increasing muscle mass, maintaining and / or improving muscle strength, and improving palatability. In addition, the composition of the present invention has a mitochondrial activation effect and an amino acid absorption promoting effect, and therefore has excellent effects of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] The present invention will be described in detail below.

[0010] [1. Protein] The present invention uses protein as an essential component. The protein used in the present invention may be an animal protein, a vegetable protein, a microbial protein, or a combination thereof. Examples of animal proteins include milk-derived proteins such as whey protein (milk serum) and casein protein, egg-derived proteins such as chicken eggs, egg yolks, and egg whites, silk proteins, and insect proteins. Examples of vegetable proteins include cereal-derived proteins such as wheat-derived proteins, soybean-derived proteins, rice-derived proteins, pigeon oat-derived proteins, oat-derived proteins, corn-derived proteins, pea-derived proteins, and fava bean-derived proteins, almond-derived proteins, potato-derived proteins, potato-derived proteins such as potato waste, hemp seed-derived proteins, cranberry-derived proteins, and algae-derived proteins. Examples of microbial-derived proteins include fungal proteins such as yeast-derived proteins, koji-derived proteins, and mushroom-derived proteins, and bacterial proteins such as natto bacteria-derived proteins and lactic acid bacteria-derived proteins. In the present invention, milk-derived proteins such as whey protein and casein protein, egg-derived proteins such as chicken eggs, egg yolks, and egg whites, wheat-derived proteins, soybean-derived proteins, rice-derived proteins, pea-derived proteins, fungal-derived proteins, and bacterial-derived proteins are preferred, and milk-derived proteins such as whey protein and casein protein, egg-derived proteins such as chicken eggs, egg yolks, and egg whites, soybean-derived proteins, pea-derived proteins, fungal-derived proteins, and bacterial-derived proteins are more preferred, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, whey protein, casein protein, egg-derived proteins such as chicken eggs, egg yolks, and egg whites, soybean-derived proteins, pea-derived proteins, fungal-derived proteins, and bacterial-derived proteins are particularly preferred. The proteins used in the present invention are hydrolyzed (peptides), concentrated (concentrates), and high-purity (isolates). In addition, in the present invention, protein-containing raw materials containing components other than proteins such as excipients can also be used.The average molecular weight (weight average molecular weight) of the protein is not particularly limited, but is preferably, for example, 300 to 100,000, and more preferably 500 to 80,000.

[0011] The protein content in the composition of the present invention is not particularly limited, but from the viewpoint of exerting an excellent effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, the protein-containing raw material preferably contains 20 to 95% by mass, more preferably 30 to 93% by mass, particularly preferably 40 to 91% by mass, and particularly preferably 50 to 90% by mass, in terms of dry weight. The protein content in the raw material used is preferably 40% by mass or more, more preferably 50% by mass or more, in terms of exerting an effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, and particularly preferably 60% by mass or more.

[0012] [2. Plant materials] The composition of the present invention contains as essential ingredients a protein and at least one plant material selected from black cumin, Pfaffia, and Eleuthero. Each plant material will be described in detail below.

[0013] (Black cumin) Black cumin is a flowering annual plant belonging to the Nigella genus of the Ranunculaceae family, with the scientific name "Nigella sativa" and the Japanese name "Nioi Kurotanesou." Black cumin contains ingredients such as thymoquinone.

[0014] The part used in the present invention is preferably a seed (black cumin seed) because it contains a lot of thymoquinone and can better enjoy the effects of black cumin. Black cumin is not particularly limited as long as it is a commonly known processed product of black cumin, and for example, crushed product and its dried powder (also called crushed powder), finely sliced ​​product, squeezed juice and its dried powder (also called squeezed juice powder), and extract and its dried powder (also called extract powder) can be used. In the present invention, extract powder is preferred because it can better enjoy the effects of black cumin.

[0015] The extraction method includes supercritical extraction, solvent extraction, water distillation, steam distillation, microwave extraction, squeezing (cold press), etc., and supercritical extraction is preferred because it can extract more thymoquinone and can enjoy the effects of the present invention more. The solvent used in supercritical extraction is preferably a solvent with a critical temperature of 600K or less, for example, carbon dioxide, saturated hydrocarbons, alcohol, etc., and carbon dioxide, saturated hydrocarbons having 1 to 4 carbon atoms, and monohydric alcohols having 1 to 4 carbon atoms are preferred, and carbon dioxide is particularly preferred. These solvents may be used alone or in combination of two or more. When two or more solvents are used in combination, at least one of the solvents may be in a supercritical state.

[0016] In the case of supercritical extraction using carbon dioxide, for example, black cumin can be filled into an extraction vessel, and carbon dioxide pressurized to a required pressure is passed through the vessel at a predetermined speed, and then the pressure is reduced to recover the extract. Note that the black cumin extract also includes those that have been subjected to processing such as heating, drying, and crushing in addition to the extraction treatment.

[0017] In addition, the solvent used for the solvent extraction is preferably a hydrophilic solvent such as water, ethanol, aqueous ethanol, 1,3-butylene glycol (BG), aqueous BG, etc., from the viewpoint of being able to enjoy the effects of black cumin more, and water and aqueous ethanol are particularly preferred. In addition, the temperature of each solvent can be appropriately set within the range of room temperature to the boiling point or lower.

[0018] In the present invention, from the viewpoint of enjoying the effects of black cumin, it is preferable to contain thymoquinone. The content of thymoquinone contained in black cumin is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and even more preferably 1.0% by mass or more. From the viewpoint of easy continuous oral intake in daily life, the content of thymoquinone contained in black cumin is preferably 70% by mass or less, more preferably 50% by mass or less, and particularly preferably 30% by mass or less.

[0019] In the present invention, the content of thymoquinone contained in black cumin and the content of thymoquinone in the composition can be analyzed by, for example, HPLC.

[0020] The content of black cumin in the composition of the present invention is not particularly limited, but from the viewpoint of enhancing the effects of the present invention, it is preferably 0.001 to 50 mass%, more preferably 0.01 to 40 mass%, and particularly preferably 0.1 to 30 mass% in the solid content. In particular, in the case of granules and powders, it is preferably 0.1 to 50 mass%, more preferably 1 to 40 mass%, and particularly preferably 2 to 30 mass%. In the case of bar-shaped foods, it is preferably 0.01 to 10 mass%, more preferably 0.1 to 5 mass%, and particularly preferably 0.1 to 2.5 mass%, from the viewpoint of enhancing the effects of the present invention. In addition, in the case of liquid beverages containing a solvent such as water, it is preferably 0.001 to 5 mass%, more preferably 0.01 to 2.5 mass%, and particularly preferably 0.05 to 1 mass%, from the viewpoint of enhancing the effects of the present invention.

[0021] The content of thymoquinone in the composition of the present invention is not limited, and thymoquinone may not be contained, but from the viewpoint of easily enjoying the effects of black cumin, it is preferable to contain 0.0001% by mass or more, more preferably 0.001% by mass or more, even more preferably 0.01% by mass or more, and particularly preferably 0.1% by mass or more, in terms of dry mass conversion.In addition, from the viewpoint of easy continuous oral intake of the obtained composition in daily life, it is more preferable to contain 20% by mass or less of thymoquinone, preferably 15% by mass or less, even more preferably 10% by mass or less, and particularly preferably 5% by mass or less, in terms of dry mass conversion.

[0022] The amount of black cumin taken in the present invention is not particularly limited, but from the viewpoint of easily enjoying the effects of black cumin, the amount of black cumin taken is preferably 10 mg or more per day for an adult, more preferably 50 mg or more, and particularly preferably 100 mg or more. Also, from the viewpoint of easy continuous oral intake in daily life, the amount of black cumin taken is preferably 2000 mg or less per day, more preferably 1000 mg or less, and particularly preferably 500 mg or less.

[0023] (Pfaffia) Pfaffia is a plant of the genus Pfaffia in the family Amaranthaceae. It grows naturally in South America and is also called Brazilian ginseng, Amazonian ginseng, and Nanbei ginseng. Examples of Pfaffia that can be used in the present invention include Pfaffia glomerata (Pfaffia glomerata). glomerate, P.iresinoides, P.paniculata, P.jubata, P.pulverulenta, P.spicata, P.actifolia, P.aphylla, P.cinerea, P.denudata, P.elata, P.equisetiformis, P.eriantha antha, P. glabrata, P. glabratoides, P. gnaphaloides, P. helichrysoides, P. hirtula, P. lanata, P. reticulata, P. stenophyla, P. tuberosa and P. velutina, etc., and one or more of these can be used. Among them, P. glomerate and P. iresinoides are preferably used.

[0024] The part used in the present invention is preferably the root, which contains a large amount of 20-hydroxyecdysone and allows the effects of Pfaffia to be enjoyed more. There are no particular limitations on the Pfaffia, so long as it is a commonly known processed product of Pfaffia, and for example, crushed products and their dried powders (also called crushed powder), shredded products, squeezed juice and its dried powders (also called squeezed juice powder), and extracts and their dried powders (also called extract powder) can be used. In the present invention, extract powder is preferred, from the viewpoint of allowing the effects of Pfaffia to be enjoyed more.

[0025] Examples of the extraction method include supercritical extraction and solvent extraction. Solvent extraction is preferred because it can extract more 20-hydroxyecdysone and can enjoy the effects of Pfaffia. As the solvent used for solvent extraction, hydrophilic solvents such as water, ethanol, aqueous ethanol, 1,3-butylene glycol (BG), and aqueous BG are preferred because they can enjoy the effects of the present invention and are easy to incorporate into the composition, and water and aqueous ethanol are particularly preferred. The temperature of each solvent can be appropriately set between room temperature and the boiling point. In solvent extraction using aqueous ethanol, for example, Pfaffia is weighed in an extraction vessel, extracted with aqueous ethanol, and then filtered and concentrated to recover the extract. In addition, Pfaffia extracts also include those that have been subjected to processing such as heating, drying, and crushing in addition to extraction processing.

[0026] In the present invention, from the viewpoint of enjoying the effects of Pfaffia more, it is preferable that Pfaffia contains 20-hydroxyecdysone. The content of 20-hydroxyecdysone contained in Pfaffia is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and even more preferably 0.5% by mass or more. From the viewpoint of easy continuous oral intake in daily life, the content of 20-hydroxyecdysone contained in Pfaffia is preferably 70% by mass or less, more preferably 50% by mass or less, and particularly preferably 30% by mass or less.

[0027] In the present invention, the content of 20-hydroxyecdysone contained in Pfaffia and the content of 20-hydroxyecdysone in the composition can be analyzed by, for example, HPLC.

[0028] The content of Pfaffia in the composition of the present invention is not particularly limited, but from the viewpoint of enhancing the effects of the present invention, it is preferably 0.0001 to 40 mass%, more preferably 0.001 to 30 mass%, and particularly preferably 0.01 to 20 mass% in the solid content. In particular, in granules and powders, it is preferably 0.001 to 40 mass%, more preferably 0.01 to 30 mass%, and particularly preferably 0.1 to 20 mass%. In bar-shaped foods, it is preferably 0.001 to 5 mass%, more preferably 0.01 to 2.5 mass%, and particularly preferably 0.1 to 1 mass%, from the viewpoint of enhancing the effects of the present invention. In addition, in liquid beverages containing a solvent such as water, it is preferably 0.0001 to 5 mass%, more preferably 0.001 to 2.5 mass%, and particularly preferably 0.01 to 1 mass%, from the viewpoint of enhancing the effects of the present invention.

[0029] The content of 20-hydroxyecdysone in the composition of the present invention is not limited, and 20-hydroxyecdysone may not be contained, but from the viewpoint of easily enjoying the effects of Pfaffia, it is preferable to contain 0.00001% by mass or more, more preferably 0.0001% by mass or more, even more preferably 0.001% by mass or more, and particularly preferably 0.01% by mass or more, calculated as a dry mass. Also, from the viewpoint of easily continuously orally ingesting the obtained composition in daily life, it is preferable to contain 10% by mass or less of 20-hydroxyecdysone, more preferably 8% by mass or less, even more preferably 5% by mass or less, and particularly preferably 1% by mass or less, calculated as a dry mass.

[0030] The amount of Pfaffia taken in the present invention is not particularly limited, but from the viewpoint of easily enjoying the effects of Pfaffia, the amount of Pfaffia taken is preferably 0.1 mg or more per day for an adult, more preferably 1 mg or more, and particularly preferably 10 mg or more.In addition, from the viewpoint of easily continuously orally taking the obtained composition in daily life, it is preferably taken in an amount of 1000 mg or less per day, more preferably 500 mg or less, and particularly preferably 200 mg or less.

[0031] (Eleuthero) Eleutherococcus senticosus is a deciduous shrub belonging to the Araliaceae family, and its scientific name is Eleutherococcus senticosus, also known as shigoka.

[0032] The part used in the present invention is preferably the root, since it contains a lot of eleutherosides and can better enjoy the effects of Acanthopanax senticosus.Acanthopanax senticosus is not particularly limited as long as it is a commonly known processed product of Acanthopanax senticosus, and for example, crushed product and its dried powder (also called crushed powder), finely sliced ​​product, squeezed juice and its dried powder (also called squeezed juice powder), and extract and its dried powder (also called extract powder) can be used.In the present invention, extract powder is preferred, since it can better enjoy the effects of Acanthopanax senticosus.

[0033] The extraction method includes supercritical extraction, solvent extraction, etc., and solvent extraction is preferred because more eleutherosides can be extracted and the effects of Acanthopanax senticosus can be enjoyed. As the solvent used for solvent extraction, hydrophilic solvents such as water, ethanol, aqueous ethanol, 1,3-butylene glycol (BG), aqueous BG, etc. are preferred because the effects of the present invention can be enjoyed more and they can be easily incorporated into the composition, and water and aqueous ethanol are particularly preferred. In addition, the temperature of each solvent can be appropriately set between room temperature and the boiling point or lower. In the solvent extraction using aqueous ethanol, for example, Acanthopanax senticosus is weighed into an extraction vessel, extracted with aqueous ethanol, and then filtered and concentrated to recover the extract. The above-mentioned "Acanthopanax senticosus extract" also includes those that have been subjected to processing such as heating, drying, and crushing in addition to extraction processing. Specifically, the Acanthopanax senticosus Hors d'oeuvre extract of the present invention includes a liquid obtained by cutting Acanthopanax senticosus Hors d'oeuvre to an appropriate size as necessary and then adding an appropriate infusion (extraction solvent) to infuse the liquid, a concentrated liquid of the infusion (soft extract, liquid extract, tincture, etc.), and further a dried version of these (dried extract, etc.), etc.

[0034] In the present invention, from the viewpoint of enjoying the effects of Acanthopanax senticosus Harm, it is preferable to contain eleutheroside. The type of eleutheroside is not limited, and examples thereof include eleutheroside A, eleutheroside B, eleutheroside C, eleutheroside D, and eleutheroside E. From the viewpoint of enjoying the effects of Acanthopanax senticosus Harm, it is preferable to contain eleutheroside B and eleutheroside E.

[0035] In the present invention, from the viewpoint of enjoying the effects of Acanthopanax senticosus, the content of eleutherosides contained in Acanthopanax senticosus is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and even more preferably 0.5% by mass or more. From the viewpoint of easy continuous oral intake in daily life, the content of eleutherosides contained in Acanthopanax senticosus is preferably 70% by mass or less, more preferably 50% by mass or less, and particularly preferably 30% by mass or less.

[0036] In the present invention, the content of eleutheroside contained in Acanthopanax senticosus Hsinopecius and the content of eleutheroside in the composition can be analyzed by, for example, HPLC.

[0037] The content of Acanthopanax senticosus in the composition of the present invention is not particularly limited, but from the viewpoint of enhancing the effects of the present invention, it is preferably 0.001 to 40% by mass, more preferably 0.01 to 30% by mass, and particularly preferably 0.1 to 20% by mass in the solid content. In particular, in the case of granules and powders, it is preferably 0.001 to 40% by mass, more preferably 0.01 to 30% by mass, and particularly preferably 0.1 to 20% by mass. In the case of bar-shaped foods, it is preferably 0.001 to 5% by mass, more preferably 0.01 to 2.5% by mass, and particularly preferably 0.1 to 1% by mass, from the viewpoint of enhancing the effects of the present invention. In addition, in the case of liquid beverages containing a solvent such as water, it is preferably 0.0001 to 5% by mass, more preferably 0.001 to 2.5% by mass, and particularly preferably 0.01 to 1% by mass, from the viewpoint of enhancing the effects of the present invention.

[0038] The content of eleutherosides in the composition of the present invention is not limited, and eleutherosides may not be contained, but from the viewpoint of easily enjoying the effects of Acanthopanax senticosus Hsinopecius, it is preferable to contain 0.00001% by mass or more, more preferably 0.0001% by mass or more, even more preferably 0.001% by mass or more, and particularly preferably 0.01% by mass or more, calculated as dry mass. Also, from the viewpoint of easily continuously orally ingesting the obtained composition in daily life, it is preferable to contain eleutherosides in an amount of 10% by mass or less, more preferably 8% by mass or less, even more preferably 5% by mass or less, and particularly preferably 1% by mass or less, calculated as dry mass.

[0039] The amount of intake of Acanthopanax senticosus H. in the present invention is not particularly limited, but from the viewpoint of easy enjoyment of the effect of Acanthopanax senticosus H., the amount of intake of Acanthopanax senticosus H. is preferably 1 mg or more per day for an adult, more preferably 10 mg or more, and particularly preferably 50 mg or more.In addition, from the viewpoint of easy continuous oral intake in daily life, the amount of intake is preferably 2000 mg or less per day, more preferably 1000 mg or less, and particularly preferably 500 mg or less.

[0040] When the composition of the present invention is a granule, the median diameter is not particularly limited, but from the viewpoint of enhancing the effects of the present invention, it is preferably 10 to 750 μm or less, more preferably 25 to 500 μm or less, and particularly preferably 50 to 250 μm or less.

[0041] Since the composition of the present invention has a mitochondrial activation effect, it can function as a composition for maintaining and / or increasing muscle mass. Examples of compositions for maintaining and / or increasing muscle mass include so-called health foods labeled with such slogans as "for ideal muscles," "supporting an ideal body," "for building a strong body," "for supplementing protein during exercise," "for those who want to maintain their figure," "maintaining muscle mass," "preventing muscle loss," "shape-up," "for those who want to maintain their figure," "for those who want to improve their figure," "supporting body building," and the like.

[0042] In addition, since the composition of the present invention has a mitochondrial activation effect, it can function as a composition for maintaining and / or improving muscle strength. Examples of the composition of the present invention for maintaining and / or improving muscle strength include so-called health foods labeled with the following claims: "For protein deficiency in seniors", "For those who want to live an active life", "For active daily life", "For those who want to walk energetically", "For muscle strength reduction due to aging", "Maintaining and improving walking ability", "Maintaining and improving walking pitch and walking speed", "Maintaining and improving grip strength", "For reduced muscle function", "For weakened legs and hips", etc.

[0043] The form of the composition of the present invention is not particularly limited and may be any form. For example, the composition may be in a form suitable for oral use, specifically, a powder, a granule, a tablet, a liquid, a paste, a capsule such as a hard capsule or a soft capsule, a caplet, a tablet, a sausage, a kamaboko, a bar, or the like.

[0044] The packaging form of the composition of the present invention is not particularly limited and can be appropriately selected depending on the dosage form, etc., and examples thereof include blister packs such as PTPs; strip packaging; heat seals; aluminum pouches; film packaging using plastics, synthetic resins, etc.; glass containers such as vials; and plastic containers such as ampoules.

[0045] The composition of the present invention is preferably in a powder form (powder, granules, etc.) and in a form in which the mixture is mixed with water and used orally, since this prevents spoilage and is suitable for long-term storage.In addition, when the composition of the present invention is in a solid form such as a powder or tablet, it can be mixed with water to make a liquid and used orally, as described above, but it may also be used orally in a solid form according to the user's preference.

[0046] The daily usage amount of the composition of the present invention is not particularly limited, and can be appropriately set depending on the usage mode and the usage content of the user, for example, based on the user's body weight, 1 to 6000 mg / kg, preferably 5 to 4000 mg / kg, more preferably 10 to 3000 mg / kg, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it is more preferably 10 to 2000 mg / kg. The amount of the composition of the present invention used once is also not particularly limited, and for example, based on the user's body weight, it is 0.5 to 3000 mg / kg, preferably 1 to 2000 mg / kg, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it is more preferably 5 to 1000 mg / kg.

[0047] The amount of the composition of the present invention to be used per day is not particularly limited, and for example, in the case of a granule (powder) preparation, it can be 0.1 to 100 g, preferably 0.5 to 80 g, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it can be particularly preferably 1.5 to 60 g. In the case of a bar-shaped composition, it can be 15 to 200 g, preferably 20 to 150 g, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it can be particularly preferably 30 to 100 g. In the case of a liquid beverage, it can be 50 to 1000 g, preferably 100 to 800 g, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it can be particularly preferably 150 to 600 g. The amount of the composition of the present invention to be used per time can be, for example, in the case of a granule (powder) preparation, it can be 0.1 to 50 g, preferably 0.5 to 40 g, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it can be more preferably 1 to 30 g. In the case of a bar-shaped composition, the amount may be 15 to 150 g, preferably 20 to 100 g, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, the amount may be particularly preferably 30 to 60 g. In the case of a liquid beverage, the amount may be 50 to 1000 g, preferably 100 to 800 g, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, the amount may be particularly preferably 150 to 600 g.

[0048] The blending ratio of protein to specific plant material in the composition of the present invention is not particularly limited, but the protein:specific plant material ratio is preferably 100:0.001-100, more preferably 100:0.01-50, and from the viewpoint of the effects of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it is particularly preferably 100:0.1-20.

[0049] When black cumin contains thymoquinone, the protein and thymoquinone contents are not particularly limited, but the protein:thymoquinone content is preferably 10,000:0.005 to 7,000, more preferably 10,000:0.05 to 3,500, and from the viewpoint of the effects of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, the protein:thymoquinone content is particularly preferably 10,000:0.1 to 1,000.

[0050] When Pfaffia contains 20-hydroxyecdysone, the contents of protein and 20-hydroxyecdysone are not particularly limited, but the protein:20-hydroxyecdysone ratio is preferably 10,000:0.0005-700, more preferably 10,000:0.005-350, and from the viewpoint of the effect of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it is particularly preferably 10,000:0.05-150.

[0051] When Eleuthero contains eleutheroside, the contents of protein and eleutheroside are not particularly limited, but the protein:eleutheroside ratio is preferably 10,000:0.0001-3,000, more preferably 10,000:0.001-1,500, and from the viewpoint of the effects of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, it is particularly preferably 10,000:0.01-1,000.

[0052] The composition of the present invention can be produced by a known method by adding other ingredients as necessary in addition to the protein and specific plant material. The composition of the present invention can be used as an oral composition for general foods, for example, so-called health foods such as medicines (including quasi-drugs), functional foods such as specified health foods, nutritional functional foods, and functional foods whose efficacy has been approved by a designated organization. It can also be used as an external preparation such as medicines (including quasi-drugs) and cosmetics.

[0053] The composition of the present invention can be used in various forms for the purpose of obtaining the effects of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength. EXAMPLES

[0054] The present invention will now be described with reference to examples. Test 1. Evaluation of mitochondrial activation ability Mitochondria are organelles that play a central role in energy production within cells, and are also essential for muscle activity, development, and maintenance, and it is known that a decrease in their activity leads to rapid muscle atrophy. Therefore, by confirming the mitochondrial activation effect, it is possible to confirm the effect of maintaining and / or increasing muscle mass and the effect of maintaining and / or improving muscle strength. [Test substance] The following substances were used as test substances. Soybean-derived protein: Commercially available powdered soybean protein was used. Black cumin: A commercially available powdered extract of Nigella sativa seeds containing thymoquinone was used. Pfaffia: A commercially available powdered extract containing 20-hydroxyecdysone extracted from the roots of Pfaffia glomerata, Pfaffia iresinoides or other plants of the same genus (Amaranthaceae) was used. Eleutherococcus senticosus (Rupr. Et Maxim.) Maxim root extract, which is commercially available, was used. Leucine: Powdered L-leucine was used, which is commercially available as an ingredient known to have mitochondrial activation effects. Dextrin: We used commercially available dextrin, a substance that does not affect mitochondrial activity.

[0055] [Preparation of test substance] Each test substance was prepared using a differentiation-inducing medium (2% HS (horse serum)-DMEM). The compounding ratio of the test substances used in the following tests is shown in Table 1.

[0056] [Mitochondrial activity measurement] (1)37℃, 5vol%CO 2 In the incubator, 75 cm 2 Mouse myoblast cells (C2C12) were cultured in a flask in growth medium (10% FBS-DMEM). (2) The cells were suspended by trypsinization and seeded into each well of a 96-well collagen-coated plate at a cell density of 8 x 10^3 cells / well. The cells were incubated at 37°C and 5% CO 2 The cells were pre-cultured in an incubator for 24 hours. (3) After removing the medium from each well, the wells were washed twice with serum-free DMEM, and differentiation-inducing medium (2% HS-DMEM) was added at 200 μL / well. The wells were then incubated at 37°C and 5% CO 2 The cells were cultured in an incubator for 5 to 6 days. (4) The medium was changed every 2 to 3 days to allow differentiation into myotube cells. (5) After removing the medium from each well, add the medium containing the test substance at 100 μL / well and incubate at 37°C, 5% CO 2 The cells were cultured in an incubator for 24 hours. (6) A differentiation-inducing medium was used as the medium, and the total concentration of the test substance in the medium was 100 μg / mL. (7) After 24 hours of culture, the medium was removed and each well was washed twice with serum-free DMEM. Then, 50 μL of 10 μM Rhodamine 123 (Fujifilm Wako Pure Chemical Industries, Ltd.) prepared in serum-free DMEM was added to each well. (8)37℃, 5vol%CO 2 After allowing the plate to stand in an incubator for 30 minutes, the reagent was removed and each well was washed twice with PBS. (9) After removing the PBS from each well, additional PBS was added to the well and the fluorescence intensity (excitation wavelength Ex. 507 nm, fluorescence wavelength Em. 529 nm) was measured. (10) The percentage of control was calculated based on the data obtained. % of control = (Data sample - Data blank) / (Data control - Data blank) × 100 The relative values, with the value of Comparative Example 1 taken as 100, are shown in Table 1.

[0057] [Table 1]

[0058] In Comparative Examples 1 to 4 in which each test substance was added alone, the mitochondrial activity was 98.8 to 101.1% of control, whereas in Examples 1 to 3 containing protein and a specific plant component, the mitochondrial activity was significantly increased to 118.6 to 124.9%. In addition, it is understood that each Example exhibits a superior mitochondrial activation effect compared to Comparative Example 6 containing protein and leucine, which is known to have a mitochondrial activation effect. From the above, it is understood that the composition of the present invention has a superior mitochondrial activation effect, and therefore has a muscle mass maintenance and / or increase effect and a muscle strength maintenance and / or improvement effect. That is, the composition of the present invention is useful as a composition for maintaining and / or increasing muscle mass and a composition for maintaining and / or improving muscle strength.

[0059] Test 2. Evaluation of amino acid absorption promotion The composition of the present invention was used to confirm the amino acid absorption promotion effect by the monolayer permeability of a human colon cancer-derived cell line. The monolayer permeability of a human colon cancer-derived cell line is a common in vitro model used to evaluate the absorption of compounds through the human intestine. By confirming the amino acid permeability, the muscle-building effect and muscle strength maintenance effect by the amino acid absorption promotion can be confirmed. [Test substance] The test substances used were the same as those used in Test 1, as well as the following: Vitamin D: Powdered vitamin D, which is commercially available as an ingredient known to activate chondrocytes, was used. Dextrin: We used commercially available dextrin, a substance that does not affect amino acid absorption.

[0060] [Amino acid absorption measurement] (1)37℃, 5vol%CO 2 In the incubator, 75 cm 2 Human colon cancer cells were cultured in flasks containing 10% FBS-1% NEAA-DMEM. (2) The cells were suspended by trypsinization and seeded into insert wells of a 24-well plate at a cell density of 4 x 10^4 cells / well. The cells were incubated at 37°C and 5% CO 2 The cells were pre-cultured in an incubator for 24 hours. (3) After 24 hours, the medium was changed, and then the cells were cultured for 14 to 15 days with medium changes every 3 to 4 days to form a monolayer. (4) The electrical resistance was measured and the sample was washed with HBSS buffer. (5) The test substance was subjected to enzymatic treatment with pepsin and pancreatin according to the following procedure. As a control, ultrapure water containing no test substance was also subjected to the enzymatic treatment in the same manner. The test substance was dissolved in ultrapure water and preincubated in a block heater at 37°C. The pH was adjusted to 2.0 with 0.5N-HCl, and 100 μL of a pepsin solution adjusted to 20 μg / mL with 10 mM-HCl was added. After incubation in a water bath at 37°C for 1 hour, the pH was adjusted to 7.5 with 0.5N NaOH, and ultrapure water was added so that the total liquid volume in the tube became 1.5 mL. A pancreatin solution adjusted to 8 mg / mL with ultrapure water was added at 100 μg / mL, and the mixture was incubated in a water bath at 37°C for 1 hour. After incubation, ultrapure water was added to adjust the concentration to 25 mg / mL. (6) The enzyme-treated test substance was added to a final concentration of 8.33 mg / mL and incubated at 37°C and 5% CO 2 The cells were cultured in an incubator for 2 hours. (7) The amino acid concentration in the permeate was measured using an L-amino acid quantification kit (Sigma-Aldrich). (8) The relative values ​​with the control value set at 1 are shown in Table 2.

[0061] [Table 2]

[0062] In Comparative Examples 7 to 10, in which soybean-derived protein or a specific other component was added alone, the relative value of the amount of amino acid absorption when the amount of absorption of the control was taken as 1 was 0.85 to 2.19, and the increase was 1.19 at most, which was lower than the amount of absorption of the control. In contrast, in Examples 4 to 6, which contained soybean-derived protein and a specific other component, the relative value was 2.67 to 3.42. Although the total amount of the test substance added was the same in each Comparative Example and Example, the increase in the Examples was higher than the total increase (and decrease) in the amount of absorption of the control in each Comparative Example, and it can be seen that the amount of amino acid absorption was significantly increased. On the other hand, it can be seen that each Example exhibits a superior amino acid absorption enhancing effect compared to the increase of 1.26 in the amount of amino acid absorption in Comparative Example 12, which contained protein and vitamin D, which is known to have an amino acid absorption enhancing effect. From the above, it can be seen that the oral composition of the present invention has an excellent amino acid absorption enhancing effect, and therefore has a muscle building effect and a muscle strength maintaining effect due to the promotion of amino acid absorption. That is, the oral composition of the present invention is useful as an oral composition for promoting amino acid absorption, an oral composition for building muscle, or an oral composition for maintaining muscle strength.

[0063] 3. Sensory Test The taste improving effect of the composition of the present invention was confirmed. [Test substance] The test substances used were the same as those used in Test 1, as well as the following: Pea protein: Commercially available pea protein powder was used. Whey protein: Commercially available powdered whey protein was used. Casein protein: Commercially available powdered milk-derived casein protein was used. Egg white protein: Powdered egg white protein obtained by enzymatic hydrolysis of commercially available egg white was used. Dextrin: We used commercially available dextrin, a substance that does not affect the taste.

[0064] Each sample was obtained by mixing 10 g of powder sample with 100 ml of water according to the blending ratio shown in Table 3. The samples were evaluated for the presence or absence of a flavor characteristic of protein. The sensory evaluation was performed by panelists who regularly consume protein drinks and have experience in sensory evaluation. The evaluation results are shown in Table 3.

[0065] Next, 10 g of the powder sample was mixed with 100 ml of water according to the blending ratio shown in Table 4 to obtain each sample. These samples were compared with each protein alone and evaluated for the protein-specific flavor based on the following criteria. The sensory evaluation was performed by panelists who regularly consume protein drinks and have experience in sensory evaluation. The evaluation results are shown in Table 4. <Protein-specific odor> ◎: Does not have a sulfur-like odor and tastes much better than the standard product. ○: Has less of a sulfur-like odor and tastes better than the standard product. △: Similar to the standard product. ×: Below standard.

[0066] [Table 3]

[0067] [Table 4]

[0068] As shown in Table 3, proteins have a common, unique flavor regardless of their origin. As shown in Table 4, soybean-derived proteins were selected from the proteins and evaluated for the ability to improve the unique flavor common to proteins by combining them with the plant material of the present invention. In all cases, the taste was improved, demonstrating superior palatability.

[0069] A powder formulation was prepared according to the composition shown in Table 5. The oral composition obtained in the following preparation example contains protein and black cumin, so that by suspending 20 g in water and taking it once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the composition also has excellent palatability.

[0070] [Table 5]

[0071] A powder formulation was prepared according to the composition shown in Table 6. The oral composition obtained in the following preparation example contains protein and black cumin, so that by suspending 20 g in water and taking it once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the composition also has excellent palatability.

[0072] [Table 6]

[0073] Protein bars were produced according to the composition shown in Table 7 below. The oral composition obtained in the following production example contains protein and black cumin, so by taking 40 g once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the composition also has excellent palatability.

[0074] [Table 7]

[0075] A liquid beverage was produced according to the composition shown in Table 8 below. The oral composition obtained in the following production example contains protein and black cumin, so by taking 350 ml once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the beverage also has excellent palatability.

[0076] [Table 8]

[0077] Granules were prepared according to the composition shown in Table 9. The oral composition obtained in the following preparation example contains protein and Pfaffia, so that by suspending 20 g in water and taking it once a day, the excellent effects of the present invention, such as maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, can be enjoyed, and the composition is also highly palatable.

[0078] [Table 9]

[0079] A powder formulation was prepared according to the composition shown in Table 10. The oral composition obtained in the following preparation example contains protein and Pfaffia, so that by suspending 20 g in water and taking it once a day, the excellent effects of the present invention, such as maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, can be enjoyed, and the composition also has excellent palatability.

[0080] [Table 10]

[0081] Protein bars were produced according to the composition shown in Table 11 below. The oral composition obtained in the following production example contains protein and Pfaffia, so by taking 40 g once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the composition also has excellent palatability.

[0082] [Table 11]

[0083] A liquid beverage was produced according to the composition shown in Table 12. The oral composition obtained in the following production example contains protein and Pfaffia, so that by taking 350 ml once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the beverage also has excellent palatability.

[0084] [Table 12]

[0085] Granules were prepared according to the composition shown in Table 13. The oral composition obtained in the following preparation example contains protein and Acanthopanax senticosus Hsinopecius, and therefore by suspending the composition in water and taking 20 g of the composition once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the composition also has excellent palatability.

[0086] [Table 13]

[0087] Powders were prepared according to the compositions shown in Table 14. The oral compositions obtained in the following preparation examples contain protein and Acanthopanax senticosus Hsinopecius, and therefore by suspending the composition in water and taking 20 g of the composition once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the composition also has excellent palatability.

[0088] [Table 14]

[0089] Protein bars were produced according to the compositions shown in Table 15. The oral compositions obtained in the following production examples contain protein and Acanthopanax senticosus Harms, so that by taking 40 g of the composition once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the compositions are also highly palatable.

[0090] [Table 15]

[0091] Liquid beverages were produced according to the compositions shown in Table 16 below. The oral compositions obtained in the following production examples contain protein and Acanthopanax senticosus Harms, so by taking 350 ml once a day, the excellent effects of the present invention of maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength can be enjoyed, and the beverages also have excellent palatability.

[0092] [Table 16] [Industrial Applicability]

[0093] The composition of the present invention has excellent effects in maintaining and / or increasing muscle mass and maintaining and / or improving muscle strength, and is therefore highly industrially useful.

Claims

[Claim 1] A composition comprising a protein and at least one specific plant material selected from black cumin, Pfaffia, and Eleuthero.

Citation Information

Patent Citations

  • Nutritional supplementary food containing fruit sugar, protein with reduced molecular weight, and black pepper extract

    JP2019149984A